Search

Your search keyword '"Nitta, Hideaki"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Nitta, Hideaki" Remove constraint Author: "Nitta, Hideaki"
147 results on '"Nitta, Hideaki"'

Search Results

2. Possible New Histological Prognostic Index for Aggressive Mature T-cell Lymphoma (TCL Urayasu Classification)— a Brief Review of the Literature on the Functional Proteins Involved in Refractory Hematologic Malignancy—

3. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma

5. Possible New Histological Prognostic Index for Large B-Cell Lymphoma

7. Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms

8. A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms

9. Additional file 2 of Application of objective structured clinical examination (OSCE) for the evaluation of Kampo medicine training

10. Additional file 4 of Application of objective structured clinical examination (OSCE) for the evaluation of Kampo medicine training

11. Additional file 3 of Application of objective structured clinical examination (OSCE) for the evaluation of Kampo medicine training

12. Additional file 1 of Application of objective structured clinical examination (OSCE) for the evaluation of Kampo medicine training

13. Additional file 5 of Application of objective structured clinical examination (OSCE) for the evaluation of Kampo medicine training

16. Application of Objective Structured Clinical Examinations (OSCE) for The Evaluation of Kampo Medicine Training

18. Effective learning strategies for Japanese Kampo medicine using problem‐based learning and simulator training for medical students: A questionnaire survey

21. A peptide-aluminum complex as a novel chiral Lewis acid. Asymmetric addition of cyanotrimethylsilane to aldehydes

22. Peptide-titanium complex as catalyst for asymmetric addition of hydrogen cyanide aldehyde

23. JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera

28. Hepatobiliary and Pancreatic: Degenerative hepatic hemangioma mimicking biliary cystadenocarcinoma

29. Study of patient risk factors for febrile neutropenia in non-Hodgkin lymphoma receiving R-CHOP regimen: STOP FN single institution analysis in Japan.

30. The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

31. Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

33. Higher Titer of Epstein-Barr Virus Nuclear Antigen Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

34. 80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

36. R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL

38. RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens

39. ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma

40. Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma (DLBCL) Cases at a Single Institution

45. Neuroendocrine tumor in the Glissonean pedicle of the hepatic hilum

Catalog

Books, media, physical & digital resources